Also of interest
-
Gene therapy in sickle cell and thalassaemia – where cutting-edge science meets clinical need
What does the approval for human use of new gene editing techniques mean for patients?
An audit of compliance with the British Society for Haematology (BSH) guideline on transfusion for fetuses, neonates and older children
July 2020